Zhao Chao, An Jiahui, Li Mingzhu, Li Jingran, Zhao Yun, Wang Jianliu, Xie Heidi Qunhui, Wei Lihui
Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
Cancers (Basel). 2024 May 31;16(11):2107. doi: 10.3390/cancers16112107.
Both cervical cancer and cervical intraepithelial neoplasia (CIN) are associated with human papillomavirus (HPV) infection at different anogenital sites, but the infection features of high-risk (HR) HPVs at these sites and their association with cervical lesions have not been well characterized. Given the limitation of cervical HPV 16/18 test in screening patients with high-grade CIN (CIN 2+), studies on whether non-16/18 HR-HPV subtype(s) have potential as additional indicator(s) to improve CIN 2+ screening are needed.
The infection of 15 HR-HPVs in vulva, anus, vagina, and cervix of 499 Chinese women was analyzed, and CIN lesion-associated HR-HPV subtypes were revealed.
In addition to the well-known cervical-cancer-associated HPV 16, 52, and 58, HPV 51, 53, and 56 were also identified as high-frequency detected subtypes prevalently and consistently present at the anogenital sites studied, preferentially in multi-infection patterns. HPV 16, 52, 58, 56, and 53 were the top five prevalent subtypes in patients with CIN 2+. In addition, we found that cervical HPV 33/35/52/53/56/58 co-testing with HPV 16/18 might improve CIN 2+ screening performance.
This study provided a new insight into HR-HPV screening strategy based on different subtype combinations, which might be used in risk stratification clinically.
宫颈癌和宫颈上皮内瘤变(CIN)均与不同肛门生殖器部位的人乳头瘤病毒(HPV)感染相关,但这些部位高危(HR)HPV的感染特征及其与宫颈病变的关联尚未得到充分表征。鉴于宫颈HPV 16/18检测在筛查高级别CIN(CIN 2+)患者方面存在局限性,需要研究非16/18 HR-HPV亚型是否有潜力作为改善CIN 2+筛查的额外指标。
分析了499名中国女性外阴、肛门、阴道和宫颈中15种HR-HPV的感染情况,并揭示了与CIN病变相关的HR-HPV亚型。
除了众所周知的与宫颈癌相关的HPV 16、52和58外,HPV 51、53和56也被确定为在研究的肛门生殖器部位普遍且持续高频检测到的亚型,且多以多重感染模式出现。HPV 16、52、58、56和53是CIN 2+患者中最常见的五种亚型。此外,我们发现HPV 33/35/52/53/56/58与HPV 16/18联合检测可能会提高CIN 2+的筛查性能。
本研究为基于不同亚型组合的HR-HPV筛查策略提供了新的见解,可用于临床风险分层。